InsiderPulse
Dashboard

ATTO

Attovia Therapeutics, Inc.

Health CareRussell 2000

Attovia Therapeutics, Inc. insider trading

Attovia Therapeutics, Inc. files with the SEC as a Biological Products, (No Diagnostic Substances) company headquartered in San Carlos, CA. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent ATTO insider transactions

6 insiders traded ATTO on the open market between Aug 05, 2026 and Aug 06, 2026 — 8 purchases worth $50.6M, 16 sales worth $440.2K.

Bought
$50.6M
Sold
$440.2K

none on a 10b5-1 plan

Net
+$50.1M
Insiders
6

Open-market purchases (code P) and sales (code S) from Attovia Therapeutics, Inc.'s own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 23, 2026. The live dashboard shows new filings the moment they clear.

Every ATTO Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

ATTO insider trading by quarter

No open-market purchase or sale by a Attovia Therapeutics, Inc. insider appears in SEC's Form 4 data for trades between Jul 01, 2024 and Jun 30, 2026. Grants, option exercises, gifts and tax withholding are not counted as trades.

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Attovia Therapeutics, Inc. company record

SEC industry classification
Biological Products, (No Diagnostic Substances)
Headquarters
San Carlos, CA
Incorporated in
DE
Listed on
Nasdaq
SEC Central Index Key
0002058707

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought ATTO

What the stock actually did in the 90 days following each open-market purchase

Don't check ATTO — let it ping you

Get told the moment an insider moves on ATTO

Pro watches Attovia Therapeutics, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add ATTO to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track ATTO on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read ATTO insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

DNTHUTHRCORTHRMYSUPNOMCLHQYDOCSOSCRALHCASTHBDX
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are ATTO insiders buying or selling?
Between Aug 05, 2026 and Aug 06, 2026, 6 Attovia Therapeutics, Inc. insiders made 8 open-market purchases worth $50.6M and 16 sales worth $440.2K, a net purchase of $50.1M.
How much ATTO stock have insiders bought and sold in the last two years?
None on the open market: no purchase or sale by a Attovia Therapeutics, Inc. insider appears in SEC's Form 4 data for trades between Jul 01, 2024 and Jun 30, 2026. Grants, option exercises, gifts and tax withholding are not counted as trades.
What was the largest recent ATTO insider trade?
Frazier Life Sciences XI, L.P. (10% Owner) bought $10M of ATTO stock on Aug 06, 2026 at about $17.00 a share.
When did an insider last buy ATTO shares?
The most recent open-market purchase on file is Walsh Colin (Director) buying $8.5M on Aug 06, 2026. The largest purchase in the period was $10M by Frazier Life Sciences XI, L.P..
Where does ATTO insider trading data come from?
From the Form 4 filings Attovia Therapeutics, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.